|
End-of-day quote
Taipei Exchange
2026-10-30
|
5-day change | 1st Jan Change | ||
| 45.75 TWD | +1.22% |
|
-0.87% | -10.82% |
Company Valuation: Sagittarius Life Science Corp
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 1,113 | 895 | 1,325 | 1,699 | 1,040 | 3,465 |
| Change | - | -19.59% | 48% | 28.26% | -38.79% | 233.24% |
| Enterprise Value (EV) 1 | 756.5 | 564.1 | 1,066 | 1,497 | 889.7 | 2,662 |
| Change | - | -25.43% | 89.02% | 40.38% | -40.56% | 199.19% |
| P/E | -15.1x | -10.4x | -17.9x | -30.9x | -21.4x | -55.9x |
| PBR | 1.9x | 1.73x | 3x | 3.3x | 2.55x | 3.32x |
| PEG | - | -0.6x | 1.3x | 1.2x | 1.8x | 1.5x |
| Capitalization / Revenue | 1.99x | 1.52x | 2.5x | 3.86x | 2.22x | 10x |
| EV / Revenue | 1.36x | 0.96x | 2.02x | 3.4x | 1.9x | 7.69x |
| EV / EBITDA | -12.3x | -6.9x | -14.2x | -25.9x | -15.8x | -50.1x |
| EV / EBIT | -10.5x | -6.27x | -13x | -23.3x | -14.5x | -45.5x |
| EV / FCF | -13.8x | -36.4x | -21.2x | -53.1x | -25.6x | -130x |
| FCF Yield | -7.23% | -2.75% | -4.72% | -1.88% | -3.9% | -0.77% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -2.272 | -2.655 | -2.28 | -1.691 | -1.491 | -0.9184 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 558.2 | 587.6 | 529.1 | 440.5 | 467.8 | 346.1 |
| EBITDA 1 | -61.61 | -81.73 | -74.85 | -57.68 | -56.16 | -53.16 |
| EBIT 1 | -71.8 | -90.01 | -82.23 | -64.38 | -61.56 | -58.51 |
| Net income 1 | -74.12 | -86.42 | -74.2 | -55.04 | -48.53 | -49.56 |
| Net Debt 1 | -356.6 | -330.9 | -258.4 | -202.1 | -150.1 | -803.2 |
| Reference price 2 | 34.20 | 27.50 | 40.70 | 52.20 | 31.95 | 51.30 |
| Nbr of stocks (in thousands) | 32,546 | 32,546 | 32,546 | 32,546 | 32,546 | 67,546 |
| Announcement Date | 3/31/21 | 3/31/22 | 3/31/23 | 3/21/24 | 3/27/25 | 3/30/26 |
1TWD in Million2TWD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 94.7M | |
| 22.13x | 2.98x | 14.67x | 3.71% | 264B | |
| 19.78x | 2.56x | 15.17x | 3.15% | 82.2B | |
| 17.61x | 1.81x | 10.32x | 3.57% | 47.06B | |
| 14.23x | 0.51x | 9.17x | 2.72% | 37.07B | |
| 19.13x | 3.04x | 12.2x | 3.47% | 33.28B | |
| 35.04x | 3.03x | 17.67x | 1.06% | 31.02B | |
| 29.64x | 5.83x | 19.18x | 3.06% | 30B | |
| -8.58x | 1.86x | 9.3x | 6.59% | 28.86B | |
| Average | 18.62x | 2.70x | 13.46x | 3.41% | 61.56B | |
| Weighted average by Cap. | 20.22x | 2.75x | 13.99x | 3.5% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 3205 Stock
- Valuation Sagittarius Life Science Corp
Select your edition
All financial news and data tailored to specific country editions
